UroGen Pharma Ltd.URGNNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Trend
Above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
0.00%
↑ 100% above average
Average (39q)
-83.11%
Historical baseline
Range
High:254.01%
Low:-3278.19%
Volatility
-4249.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 100.00% |
| Q1 2025 | -16.88% |
| Q4 2024 | -58.46% |
| Q3 2024 | 29.13% |
| Q2 2024 | -3.46% |
| Q1 2024 | -24.10% |
| Q4 2023 | -18.91% |
| Q3 2023 | 9.35% |
| Q2 2023 | 20.11% |
| Q1 2023 | -4.66% |
| Q4 2022 | -11.76% |
| Q3 2022 | 3.22% |
| Q2 2022 | 5.99% |
| Q1 2022 | 0.21% |
| Q4 2021 | 5.82% |
| Q3 2021 | -15.21% |
| Q2 2021 | -1.11% |
| Q1 2021 | 15.04% |
| Q4 2020 | -5.93% |
| Q3 2020 | 8.08% |
| Q2 2020 | 17.05% |
| Q1 2020 | 3.03% |
| Q4 2019 | -75.14% |
| Q3 2019 | 1.00% |
| Q2 2019 | -4.82% |
| Q1 2019 | 9.58% |
| Q4 2018 | -15.51% |
| Q3 2018 | -13.91% |
| Q2 2018 | -34.70% |
| Q1 2018 | -32.93% |
| Q4 2017 | -3278.19% |
| Q3 2017 | 95.19% |
| Q2 2017 | -81.42% |
| Q1 2017 | -127.78% |
| Q4 2016 | 254.01% |
| Q3 2016 | -140.79% |
| Q2 2016 | 20.30% |
| Q1 2016 | 43.98% |
| Q4 2015 | 0.00% |